Search hospitals > Florida > Miami Beach
Mount Sinai Comprehensive Cancer Center
Claim this profileMiami Beach, Florida 33140
Global Leader in Melanoma
Global Leader in Cancer
Conducts research for Tumors
Conducts research for Colorectal Cancer
Conducts research for Breast Cancer
86 reported clinical trials
5 medical researchers
Summary
Mount Sinai Comprehensive Cancer Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Melanoma, Cancer, Tumors, Colorectal Cancer, Breast Cancer and other specialties. Mount Sinai Comprehensive Cancer Center is involved with conducting 86 clinical trials across 89 conditions. There are 5 research doctors associated with this hospital, such as Michael A. Schwartz, Mike Cusnir, MD, Brian Slomovitz, and Oleg Gligich.Area of expertise
1Melanoma
Global LeaderStage IV
Stage III
PD-L1 positive
2Cancer
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Michael A. SchwartzMount Sinai Medical Center7 years of reported clinical research
Studies Cancer
Studies Lung Cancer
27 reported clinical trials
74 drugs studied
Mike Cusnir, MDMount Sinai Medical Center2 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
29 reported clinical trials
57 drugs studied
Brian SlomovitzMount Sinai Comprehensive Cancer Center2 years of reported clinical research
Studies Endometrial Cancer
Studies Ovarian Cancer
16 reported clinical trials
30 drugs studied
Oleg GligichMount Sinai Medical Center1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Cancer
9 reported clinical trials
26 drugs studied
Clinical Trials running at Mount Sinai Comprehensive Cancer Center
Cancer
Endometrial Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Pancreatic Cancer
Tumors
Breast Cancer
Lymphoma
Chronic B-Cell Leukemia
Chronic Lymphocytic Leukemia
Futibatinib + PD-1 Antibody
for Esophageal Cancer
This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors.
Recruiting1 award Phase 2
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
BMF-219
for Lung Cancer
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS mutated unresectable, locally advanced, or metastatic NSCLC (Cohort 1), PDAC (Cohort 2), and CRC (Cohort 3).
Recruiting1 award Phase 15 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai Comprehensive Cancer Center?
Mount Sinai Comprehensive Cancer Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Melanoma, Cancer, Tumors, Colorectal Cancer, Breast Cancer and other specialties. Mount Sinai Comprehensive Cancer Center is involved with conducting 86 clinical trials across 89 conditions. There are 5 research doctors associated with this hospital, such as Michael A. Schwartz, Mike Cusnir, MD, Brian Slomovitz, and Oleg Gligich.